Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells

Journal of Ethnopharmacology

Volumn 154, Issue 1, 2014, Pages 229-239

  Yin, Jinjin ^a   Luo, Yanqin ^b   Deng, Houliang ^a   Qin, Shumin ^c   Tang, Waijiao ^a   Zeng, Lu ^a   Zhou, Benjie ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Adiponectin; AMPK; Hepatic steatosis; Hugan Qingzhi tablet; Oxidative stress; PPAR

Indexed keywords

ACETYL COENZYME A OXIDASE 1; ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE I; CHINESE DRUG; FATTY ACID; FENOFIBRATE; GLUTATHIONE; HERBACEOUS AGENT; HUGAN QINGZHI; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; OXIDOREDUCTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, HUMAN; ANTIOXIDANT; OLEIC ACID; PALMITIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MEGADOSE; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY LIVER; FEMALE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPOGENESIS; LIPOLYSIS; LOW DRUG DOSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; CELL LINE; DRUG EFFECTS; METABOLISM; SPRAGUE DAWLEY RAT;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIOXIDANTS; CELL LINE; DRUGS, CHINESE HERBAL; FATTY LIVER; FEMALE; HEP G2 CELLS; HUMANS; OLEIC ACID; OXIDATIVE STRESS; PALMITIC ACID; PPAR ALPHA; RATS, SPRAGUE-DAWLEY;

EID: 84900404551     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2014.04.011     Document Type: Article

References (44)

1. W. Bochu, Z. Liancai, and C. Qi Primary study on the application of Serum Pharmacology in Chinese traditional medicine Colloids and Surfaces B: Biointerfaces 43 2005 194 197
2. M.S. Brown, and J.L. Goldstein The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 89 1997 331 340
3. H. Chen, L. Zhang, X. Li, X. Li, G. Sun, X. Yuan, L. Lei, J. Liu, L. Yin, Q. Deng, J. Wang, Z. Liu, W. Yang, Z. Wang, H. Zhang, and G. Liu Adiponectin activates the AMPK signaling pathway to regulate lipid metabolism in bovine hepatocytes Journal of Steroid Biochemistry and Molecular Biology 138C 2013 445 454
4. J. Chen, H. Zhao, Y. Yang, B. Liu, J. Ni, and W. Wang Lipid-lowering and antioxidant activities of Jiang-Zhi-Ning in Traditional Chinese Medicine Journal of Ethnopharmacology 134 2011 919 930
5. M.J. Contos, J. Choudhury, A.S. Mills, and A.J. Sanyal The histologic spectrum of nonalcoholic fatty liver disease Clinic in Liver Disease 8 2004 481 500
6. H. Dan, J. Wu, M. Peng, X. Hu, C. Song, Z. Zhou, S. Yu, and N. Fang Hypolipidemic effects of Alismatis rhizome on lipid profile in mice fed high-fat diet Saudi Medical Journal 32 2011 701 707
7. A.E. Feldstein, N.W. Werneburg, A. Canbay, M.E. Guicciardi, S.F. Bronk, R. Rydzewski, L.J. Burgart, and G.J. Gores Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway Hepatology 40 2004 185 194
8. Q. Feng, X.J. Gou, S.X. Meng, C. Huang, Y.Q. Zhang, Y.J. Tang, W.J. Wang, L. Xu, J.H. Peng, and Y.Y. Hu Qushi Huayu decoction inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in vivo and in vitro Evidence-Based Complementary and Alternative Medicine 2013 2013 184358
9. M.J. Gomez-Lechon, M.T. Donato, A. Martinez-Romero, N. Jimenez, J.V. Castell, and J.E. O'Connor A human hepatocellular in vitro model to investigate steatosis Chemico Biological Interactions 165 2007 106 116
10. A.H. Hesham Nonalcoholic fatty liver disease in children living in the obeseogenic society World Journal of Pediatrics 5 2009 245 254
11. H.W. Jeong, J.W. Lee, W.S. Kim, S.S. Choe, K.H. Kim, H.S. Park, H.J. Shin, G.Y. Lee, D. Shin, H. Lee, J.H. Lee, E.B. Choi, H.K. Lee, H. Chung, S.B. Park, K.S. Park, H.S. Kim, S. Ro, and J.B. Kim A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma Diabetes 60 2011 496 506
12. Y. Jia, M.J. Bhuiyan, H.J. Jun, J.H. Lee, M.H. Hoang, H.J. Lee, N. Kim, D. Lee, K.Y. Hwang, B.Y. Hwang, D.W. Choi, and S.J. Lee Ursolic acid is a PPAR-alpha agonist that regulates hepatic lipid metabolism Bioorganic & Medicinal Chemistry Letters 21 2011 5876 5880
13. X. Jin, Y.D. Yang, K. Chen, Z.Y. Lv, L. Zheng, Y.P. Liu, S.H. Chen, C.H. Yu, X.Y. Jiang, C.Y. Zhang, and Y.M. Li HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD Journal of Hepatology 50 2009 1019 1028
14. T.W. Jung, B.S. Youn, H.Y. Choi, S.Y. Lee, H.C. Hong, S.J. Yang, H.J. Yoo, B.H. Kim, S.H. Baik, and K.M. Choi Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A Biochemical Pharmacology 86 2013 960 969
15. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome Journal of Clinical Investigation 116 2006 1784 1792
16. M.S. Lee, D. Kim, K. Jo, and J.K. Hwang Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice Biochemical and Biophysical Research Communications 401 2010 92 97
17. P. Lefebvre, G. Chinetti, J.C. Fruchart, and B. Staels Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis Journal of Clinical Investigation 116 2006 571 580
18. Y.C. Long, and J.R. Zierath AMP-activated protein kinase signaling in metabolic regulation Journal of Clinical Investigation 116 2006 1776 1783
19. Z.Z. Meng, J.H. Hu, J.X. Chen, and G.X. Yue Xiaoyaosan decoction, a traditional chinese medicine, inhibits oxidative-stress-induced hippocampus neuron apoptosis in vitro Evidence-Based Complementary and Alternative Medicine 2012 2012 489254
20. C. Niu, C. Chen, L. Chen, K. Cheng, C. Yeh, and J. Cheng Decrease of blood lipids induced by Shan-Zha (fruit of Crataegus pinnatifida) is mainly related to an increase of PPARalpha in liver of mice fed high-fat diet Hormone and Metabolic Research 43 2011 625 630
21. S.K. Panchal, H. Poudyal, and L. Brown Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats Journal of Nutrition 142 2012 1026 1032
22. S.R. Pyper, N. Viswakarma, S. Yu, and J.K. Reddy PPARalpha: energy combustion, hypolipidemia, inflammation and cancer Nuclear Receptor Signaling 8 2010 e2
23. H. Sargin, M. Sargin, H. Gozu, A. Orcun, G. Baloglu, M. Ozisik, M. Seker, and O. Uygur-Bayramicli Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients World Journal of Gastroenterology 11 2005 5874 5877
24. Y.S. Seo, J.H. Kim, N.Y. Jo, K.M. Choi, S.H. Baik, J.J. Park, J.S. Kim, K.S. Byun, Y.T. Bak, C.H. Lee, A. Kim, and J.E. Yeon PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes Journal of Gastroenterology and Hepatology 23 2008 102 109
25. H. Shimano, N. Yahagi, M. Amemiya-Kudo, A.H. Hasty, J. Osuga, Y. Tamura, F. Shionoiri, Y. Iizuka, K. Ohashi, K. Harada, T. Gotoda, S. Ishibashi, and N. Yamada Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes Journal of Biological Chemistry 274 1999 35832 35839
26. G. Soardo, D. Donnini, L. Domenis, C. Catena, D. De Silvestri, D. Cappello, A. Dibenedetto, A. Carnelutti, V. Bonasia, C. Pagano, and L.A. Sechi Oxidative stress is activated by free fatty acids in cultured human hepatocytes Metabolic Syndrome and Related Disorders 9 2011 397 401
27. A. Tailleux, K. Wouters, and B. Staels Roles of PPARs in NAFLD: potential therapeutic targets Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 1821 2012 809 818
28. D. Tang, Z. Zhang, Y. Gao, Y. Wei, and L. Han Protective effects of serum containing Ginkgo biloba extract on glomerulosclerosis in rat mesangial cells Journal of Ethnopharmacology 124 2009 26 33
29. W.J. Tang, B.J. Zhou, and H. Zhou Pharmacodynamics research of Huganqingzhi tablet on rats with non-alcoholic fatty liver model Pharmacology and Clinics of Chinese Materia Medica 29 2013 169 172
30. D.M. Torres, C.D. Williams, and S.A. Harrison Features, diagnosis, and treatment of nonalcoholic fatty liver disease Clinical Gastroenterology and Hepatology 10 2012 837 858
31. M. Trauner, M. Arrese, and M. Wagner Fatty liver and lipotoxicity Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 1801 2010 299 310
32. S. Vidyashankar, V.R. Sandeep, and P.S. Patki Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells Toxicology in vitro 27 2013 945 953
33. B. Viollet, B. Guigas, J. Leclerc, S. Hebrard, L. Lantier, R. Mounier, F. Andreelli, and M. Foretz AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives Acta Physiologica 196 2009 81 98
34. M. Wang, R. Zhao, W. Wang, X. Mao, and J. Yu Lipid regulation effects of Polygoni Multiflori Radix, its processed products and its major substances on steatosis human liver cell line L02 Journal of Ethnopharmacology 139 2012 287 293
35. W. Xie, Y. Zhao, and L. Du Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia Journal of Ethnopharmacology 140 2012 345 367
36. A. Xu, Y. Wang, H. Keshaw, L.Y. Xu, K.S. Lam, and G.J. Cooper The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice Journal of Clinical Investigation 112 2003 91 100
37. K.Z. Xu, C. Zhu, M.S. Kim, J. Yamahara, and Y. Li Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity Journal of Ethnopharmacology 123 2009 280 287
38. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, and T. Kadowaki Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nature Medicine 8 2002 1288 1295
39. D. Yin, Z. Liu, D. Peng, Y. Yang, X. Gao, F. Xu, and L. Han Serum containing Tao-Hong-Si-Wu decoction induces human endothelial cell VEGF production via PI3K/Akt-eNOS signaling Evidence-Based Complementary and Alternative Medicine 2013 2013 195158
40. M. You, M. Matsumoto, C.M. Pacold, W.K. Cho, and D.W. Crabb The role of AMP-activated protein kinase in the action of ethanol in the liver Gastroenterology 127 2004 1798 1808
41. Y.H. Zhang, J.T. Liu, B.Y. Wen, and X.H. Xiao in vitro inhibition of proliferation of vascular smooth muscle cells by serum of rats treated with Dahuang Zhechong pill Journal of Ethnopharmacology 112 2007 375 379
42. H. Zheng, S. Li, L. Ma, L. Cheng, C. Deng, Z. Chen, C. Xie, M. Xiang, W. Jiang, and L. Chen A novel agonist of PPAR-gamma based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance European Journal of Pharmacology 659 2011 244 251
43. B. Zhou, Y. Yan, S. Huang, Y. Yao, and S. Zhang The quality standard study on Hugan Qingzhi tablets Journal of Chinese Medicinal Materials 35 2012 644 647
44. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Moller Role of AMP-activated protein kinase in mechanism of metformin action Journal of Clinical Investigation 108 2001 1167 1174